Catapres-tts-1 Patch
Product Images NDC 82089-201

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 20 technical images submitted to the FDA as part of the official labeling for Catapres-tts-1 (NDC 82089-201). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Technomed Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton-0.1 mg (Catapres Tts 1 Carton)

FDA Label Image

Pouch(front) (0.1 mg)

Pouch(front) (0.1 mg)
This is a description of a medication patch called Catapres-TTS, which delivers a specific dosage of clonidine transdermally. It is programmed for a certain amount per day for one week. There is a note about removing the patch before undergoing a magnetic resonance imaging (MRI) procedure to avoid any issues.*
FDA Label Image

Pouch(back) (0.1 mg)

Pouch(back) (0.1 mg)
This is a medication pouch that contains one system with medication. It should be stored at a temperature between 20°C and 25°C (68°F to 77°F) in a USP Controlled Room. The pouch should have the clear backing removed before use. It is manufactured by Cortum Innovations, Inc. and features the trademark of CataprosaTIS.*
FDA Label Image

Carton-0.2 mg (Catapres Tts 2 Carton)

FDA Label Image

Pouch(front) (0.2 mg)

FDA Label Image

Pouch(back) (0.2 mg)

FDA Label Image

Carton-0.3 mg (Catapres Tts 3 Carton)

FDA Label Image

Pouch(front)- 0.3 mg (Catapres Tts 3 Pouch)

FDA Label Image

Pouch(back)- 0.3 mg (Catapres Tts 3 Pouchb)

FDA Label Image

Clonidine-structure (Clonidine Structure)

FDA Label Image

Cover (0.1 mg)

Cover (0.1 mg)
This is a warning text for an adhesive cover product, stating that it does not contain active medication and should be applied over a patch if necessary. It also suggests referring to the patient information sheet for guidance on using the adhesive cover.*
FDA Label Image

Cover-0.2 mg (Cover 2)

Cover-0.2 mg (Cover 2)
This is a warning and usage information for an adhesive cover which does not contain active medication. It is suggested to apply the cover over a patch if necessary and further instructions can be found in the patient information sheet.*
FDA Label Image

Cover-0.3 mg (Cover 3)

Cover-0.3 mg (Cover 3)
This product is an adhesive cover used in conjunction with a patch. It is important to note that this cover does not contain any active medication and should be applied over the patch if necessary. Detailed instructions for the use of this adhesive cover can be found in the patient information sheet.*
FDA Label Image

Figure_1 (Figure 1)

Figure_1 (Figure 1)
Adhesive cover to be applied over patch if necessary. This product helps secure and protect the patch, ensuring it stays in place for effective treatment.*
FDA Label Image

Figure_2 (Figure 2)

Figure_2 (Figure 2)
Contains SYSTEM with Contains COVER for use medication if the SYSTEM becomes loose.*
FDA Label Image

Figure_3 (Figure 3)

FDA Label Image

Figure_4 (Figure 4)

FDA Label Image

Figure_5 (Figure 5)

FDA Label Image

Figure_6 (Figure 6)

FDA Label Image

System-cross-section (System Cross Section)

System-cross-section (System Cross Section)
This is a list of components for a drug delivery system, including backing, drug reservoir, control membrane, adhesive, and a silicone release liner.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.